Patents Assigned to Therapure Biopharma Inc.
-
Publication number: 20170282095Abstract: The present invention provides a process for the isolation of one or more proteins) from a protein solution. The process comprising the steps of: a) providing a protein solution comprising one or more specific proteins) and having a preset pH and a preset ionic strength or conductivity, b) applying the protein solution to a packed bed or expanded bed column comprising an adsorbent, and c) obtaining one or more proteins) from the column; wherein the protein solution has been supplemented with an alcohol.Type: ApplicationFiled: March 7, 2017Publication date: October 5, 2017Applicant: Therapure Biopharma Inc.Inventor: Allan Otto Fog Lihme
-
Patent number: 9624260Abstract: The present invention provides a process for the isolation of one or more proteins) from a protein solution. The process comprising the steps of: a) providing a protein solution comprising one or more specific proteins) and having a preset pH and a preset ionic strength or conductivity, b) applying the protein solution to a packed bed or expanded bed column comprising an adsorbent, and c) obtaining one or more proteins) from the column; wherein the protein solution has been supplemented with an alcohol.Type: GrantFiled: June 7, 2005Date of Patent: April 18, 2017Assignee: Therapure Biopharma Inc.Inventor: Allan Otto Fog Lihme
-
Patent number: 9428545Abstract: The present invention provides a process for the isolation of one or more proteins from a protein solution. This process comprising the steps of: a) providing a protein solution comprising one or more specific proteins and having a preset pH and a preset ionic strength or conductivity, b) applying the protein solution to a packed bed or expanded bed column comprising an adsorbent, and c) obtaining one or more proteins) from the column; wherein the protein solution has been not supplemented with an alcohol.Type: GrantFiled: April 16, 2015Date of Patent: August 30, 2016Assignee: Therapure Biopharma Inc.Inventor: Allan Otto Fog Lihme
-
Publication number: 20160009757Abstract: The present invention provides a process for the isolation of one or more proteins) from a protein solution. The process comprising the steps of: a) providing a protein solution comprising one or more specific proteins) and having a preset pH and a preset ionic strength or conductivity, b) applying the protein solution to a packed bed or expanded bed column comprising an adsorbent, and c) obtaining one or more proteins) from the column; wherein the protein solution has been supplemented with an alcohol.Type: ApplicationFiled: April 16, 2015Publication date: January 14, 2016Applicant: Therapure Biopharma Inc.Inventor: Allan Otto Fog LIHME
-
Patent number: 8840877Abstract: Method for preparing an oxidized polysaccharide-protein composition, by (a) oxidizing a polysaccharide with an oxidizing agent to form an oxidized polysaccharide where less than 20% of the oxidized units are comprised of alpha-hydroxy aldehyde units, (b) reacting the oxidized polysaccharide with a protein to form a composition comprising an oxidized polysaccharide-protein conjugate, and (c) maintaining the oxidized polysaccharide-protein conjugate composition by placing it in an environment where the temperature is less than 8° C. The oxidized polysaccharide and the protein are conjugated via one or more imine bonds, the oxidized polysaccharide-protein composition is soluble in aqueous solvent, and the composition is capable of releasing the protein.Type: GrantFiled: June 26, 2009Date of Patent: September 23, 2014Assignee: Therapure Biopharma Inc.Inventors: Gord Adamson, David Bell, Steven Brookes
-
Publication number: 20130209419Abstract: Methods and compositions for improving the engraftment of stem cells are described. The method involves administering an effective amount of hemoglobin. The methods and compositions are useful in stimulating hematopoiesis and may be used to boost human hematopoietic re-engraftment for use in transplant recipients or in patients with bone marrow injury.Type: ApplicationFiled: February 15, 2013Publication date: August 15, 2013Applicant: Therapure Biopharma Inc.Inventor: Therapure Biopharma Inc.
-
Publication number: 20120213732Abstract: This invention relates to targeted delivery of anti-viral compounds through protein bioconjugation. More particularly, it relates to an anti-viral compound conjugated to a protein, such as hemoglobin and to a method of treating a viral infection using said conjugate. The invention also provides a method of targeted drug delivery of an anti-viral nucleoside analogue to macrophages, cells comprising a hemoglobin receptor and to CD163 bearing cells.Type: ApplicationFiled: February 17, 2012Publication date: August 23, 2012Applicant: Therapure Biopharma Inc.Inventors: J. Gordon Adamson, David Bell, Nancy Ng, Petrus Biessels
-
Patent number: 7524500Abstract: Methods and compositions for stimulating the growth, proliferation, differentiation and/or mobilization of stem and/or progenitor cells are described. The method involves administering an effective amount of a substance which can activate the CD163 hemoglobin scavenger receptor signal transduction pathway. The methods and compositions are useful in stimulating hematopoiesis and in treating a wide range of conditions including cytopenias, anemias and for use in preparing cells for transplantation.Type: GrantFiled: March 26, 2002Date of Patent: April 28, 2009Assignee: Therapure Biopharma Inc.Inventors: Susan Mueller, David Bell, Kathryn Emma Matthews